Citations

Mayo Clinic

Showing 10 of 108599 citations.

Fighting and Penalty Minutes Associated With Long-term Mortality Among National Hockey League Players, 1967 to 2022
Morrissette, Cole , McCormick, Kyle L. , Gorroochurn, Prakash , Morrissette, Cole R , Popkin, Charles Aaron , Fortney, Thomas A. , Stuart, Michael J.

JAMA Network Open | May 10, 2023 | Volume: 6 | Issue: 5 | Pages: e2311308

10.1001/jamanetworkopen.2023.11308 | PMID 37163266 Get It

ImportanceNational Hockey League (NHL) players are exposed to frequent head trauma. The long-term consequences of repetitive brain injury, especially for players who frequently engage in fighting, remains unknown.ObjectiveTo investigate the mortality rates and causes of death among NHL enforcers with more career fights and penalty minutes as compared with matched controls.Design, Setting, and ParticipantsThis matched cohort study examined 6039 NHL players who participated in at least 1 game in the seasons between October 11, 1967, and April 29, 2022, using official NHL data. Cohorts designated as enforcer-fighter (E-F) and enforcer-penalties (E-P) were selected. The E-F cohort consisted of players who participated in 50 or more career fights (n = 331). The E-P cohort included players with 3 or more penalty minutes per game (n = 183). Control-matched NHL players were identified for each E-F player (control-fighter [C-F]) (n = 331) and each E-P player (control-penalties [C-P]) (n = 183).ExposuresFighting and penalty minutes were both used as proxies for head trauma exposure. Players with significantly increased exposure to fighting and penalties (E-F and E-P cohorts) were compared with NHL players with less frequent exposure to head trauma (C-F and C-P cohorts).Main Outcomes and MeasuresMortality rates and age at death of the enforcer and control cohorts, and their causes of death using data obtained from publicly available sources such as online and national news sources, including NHL.com.ResultsAmong the 6039 NHL players identified (mean [SD] age, 47.1 [15.2] years), the mean (SD) number of fights was 9.7 (24.5). The mortality rates of E-F and C-F players (13 [3.9%] vs 14 [4.2%], respectively; P = .84) or E-P and C-P players (13 [7.1.%] vs 10 [5.5%]; P = .34) were not significantly different. The mean (SD) age at death was 10 years younger for E-F players (47.5 [13.8] years) and E-P players (45.2 [10.5] years) compared with C-F players (57.5 [7.1] years) and C-P players (55.2 [8.4] years). There was a difference in causes of death between the control and enforcer players (2 neurodegenerative disorders, 2 drug overdoses, 3 suicides, and 4 vehicular crashes among enforcers vs 1 motor vehicle crash among controls; P = .03), with enforcers dying at higher rates of overdose (2 of 21 [9.5%] vs 0 of 24) and suicide (3 of 21 [14.3%] vs 0 of 24) (P = .02).Conclusions and RelevanceThe findings of this matched cohort study indicate that there is no difference in overall mortality rates between NHL enforcers and controls. However, being an enforcer was associated with dying approximately 10 years earlier and more frequently of suicide and drug overdose.
A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma
An, Zesheng , Hsu, Michelle A. , Gicobi, Joanina K. , Xu, Tianxiao , Harrington, Susan M. , Pavelko, Kevin D. , Hirdler, Jacob B. , Lohse, Christine M. , Nabavizadeh, Reza , Pessoa, Rodrigo Rodrigues , Sharma, Vidit , Thompson, R. Houston, Leibovich, Bradley C. , Pavelko, Kevin D , Pessoa, Rodrigo R, Leibovich, Bradley C , Dong, Haidong , Lucien, Fabrice , Zhang, Henan , Dong, Haidong , Lucien, Fabrice

The Journal of Immunology | May 10, 2023 | Volume: 210 | Issue: 12 | Pages: 2029-2037

10.4049/jimmunol.2200933 | PMID 37163328 Get It

Abstract The intrinsic and acquired resistance to PD-1/PD-L1 immune checkpoint blockade is an important challenge for patients and clinicians because no reliable tool has been developed to predict individualized response to immunotherapy. In this study, we demonstrate the translational relevance of an ex vivo functional assay that measures the tumor cell killing ability of patient-derived CD8 T and NK cells (referred to as “cytotoxic lymphocytes,” or CLs) isolated from the peripheral blood of patients with renal cell carcinoma. Patient-derived PBMCs were isolated before and after nephrectomy from patients with renal cell carcinoma. We compared the efficacy of U.S. Food and Drug Administration (FDA)-approved PD-1/PD-L1 inhibitors (pembrolizumab, nivolumab, atezolizumab) and a newly developed PD-L1 inhibitor (H1A Ab) in eliciting cytotoxic function. CL activity was improved at 3 mo after radical nephrectomy compared with baseline, and it was associated with higher circulating levels of tumor-reactive effector CD8 T cells (CD11ahighCX3CR1+GZMB+). Treatment of PBMCs with FDA-approved PD-1/PD-L1 inhibitors enhanced tumor cell killing activity of CLs, but a differential response was observed at the individual-patient level. H1A demonstrated superior efficacy in promoting CL activity compared with FDA-approved PD-1/PD-L1 inhibitors. PBMC immunophenotyping by mass cytometry revealed enrichment of effector CD8 T and NK cells in H1A-treated PBMCs and immunosuppressive regulatory T cells in atezolizumab-treated samples. Our study lays the ground for future investigation of the therapeutic value of H1A as a next-generation immune checkpoint inhibitor and the potential of measuring CTL activity in PBMCs as a tool to predict individual response to immune checkpoint inhibitors in patients with advanced renal cell carcinoma.
A field map updating algorithm to improve fat‐water spiral imaging
Chao, Tzu Cheng , Wang, Dinghui , Krishnamoorthy, Guruprasad , Pipe, James G.

Magnetic Resonance in Medicine | May 10, 2023 | Volume: 90 | Issue: 3 | Pages: 1219-1227

10.1002/mrm.29697 | PMID 37158313 Get It

PurposeAn accurate field map is essential to separate fat and water signals in a dual‐echo chemical shift encoded spiral MRI scan. A rapid low‐resolution B0 map prescan is usually performed before each exam. Occasional inaccuracy in these field map estimates can lead to misclassification of the water and fat signals as well as blurring artifacts in the reconstruction. The present work proposes a self‐consistent model to evaluate residual field offsets according to the image data to improve the reconstruction quality and facilitate the scan efficiency.Theory and MethodsThe proposed method compares the phase differences of the two‐echo data after correcting for fat frequency offsets. A more accurate field map is approximated according to the phase discrepancies and improved image quality. Experiments were conducted with simulated off‐resonance on a numerical phantom, five volunteer head scans, and four volunteer abdominal scans for validation.ResultsThe initial reconstruction of the demonstrated examples exhibit blurring artifacts and misregistration of fat and water because of the inaccuracy of the field map. The proposed method updates the field map to amend the fat and water estimation and improve image quality.ConclusionsThis work presents a model to improve the quality of fat‐water imaging of the spiral MRI by estimating a better field map from the acquired data. It allows reducing the field map pre‐scans before each spiral scan under normal circumstances to increase scan efficiency.
Trajectory of PaO 2 /FiO 2 Ratio in Shock After Angiotensin II
Wieruszewski, Patrick M. , Coleman, Patrick J. , Levine, Andrea R. , Davison, Danielle , Smischney, Nathan J. , Kethireddy, Shravan, Guo, Yanglin, Mazzeffi, Michael , Chow, Jonathan H. , Chow, Jonathan H , Wieruszewski, Patrick M , Smischney, Nathan J , Hecht, Jason P.

Journal of Intensive Care Medicine | May 10, 2023 | Volume: 38 | Issue: 10 | Pages: 939-948

10.1177/08850666231174870 | PMID 37161301 Get It

Introduction High-dose catecholamines can impair hypoxic pulmonary vasoconstriction and increase shunt fraction. We aimed to determine if Angiotensin II (Ang-2) is associated with improved PaO 2 /FiO 2 and SpO 2 /FiO 2 in patients in shock. Methods Adult patients at four tertiary care centers and one community hospital in the United States who received Ang-2 from July 2018-September 2020 were included in this retrospective, observational cohort study. PaO 2 , SpO 2 , and FiO 2 were measured at 13 timepoints during the 48-h before and after Ang-2 initiation. Piecewise linear mixed models of PaO 2 /FiO 2 and SpO 2 /FiO 2 were created to evaluate hourly changes in oxygenation after Ang-2 initiation. The difference in the proportion of patients with PaO 2 /FiO 2 ≤ 300 mm Hg at the time of Ang-2 initiation and 48 h after was also examined. Results The study included 254 patients. In the 48 h prior to Ang-2 initiation, oxygenation was significantly declining (hourly PaO 2 /FiO 2 change −4.7 mm Hg/hr, 95% CI − 6.0 to −3.5, p < .001; hourly SpO 2 /FiO 2 change −3.1/hr, 95% CI−3.7 to −2.4, p < .001). Ang-2 treatment was associated with significant improvements in PaO 2 /FiO 2 and SpO 2 /FiO 2 in the 48-h after initiation (hourly PaO 2 /FiO 2 change +1.5 mm Hg/hr, 95% CI 0.5-2.5, p = .003; hourly SpO 2 /FiO 2 change +0.9/hr, 95% CI 0.5-1.2, p < .001). The difference in the hourly change in oxygenation before and after Ang-2 initiation was also significant ( p interaction < 0.001 for both PaO 2 /FiO 2 and SpO 2 /FiO 2 ). This improvement was associated with significantly fewer patients having a PaO 2 /FiO 2 ≤ 300 mm Hg at 48 h compared to baseline (mean difference −14.9%, 95% CI −25.3% to −4.6%, p = .011). Subgroup analysis found that patients with either a baseline PaO 2 /FiO 2 ≤ 300 mm Hg or a norepinephrine-equivalent dose requirement >0.2 µg/kg/min had the greatest associations with oxygenation improvement. Conclusions Ang-2 is associated with improved PaO 2 /FiO 2 and SpO 2 /FiO 2 . The mechanisms for this improvement are not entirely clear but may be due to catecholamine-sparing effect or may also be related to improved ventilation-perfusion matching, intrapulmonary shunt, or oxygen delivery.
MR Elastography: Practical Questions, From the AJR Special Series on Imaging of Fibrosis
Yin, Meng , Ehman, Richard L.

American Journal of Roentgenology | May 10, 2023 | Volume: 222 | Issue: 1 | Pages: No page available

10.2214/ajr.23.29437 | PMID 37162036 Get It

Parental Leave Policies in the Top 20 US Hospitals: A Call for Inclusivity and Improvement
Khan, Aqsa , Mukkamala, Shivani G. , McMullen, Kaley, Sharperson, Camara , Strand, Natalie , McMullen, Kaley B, Sharperson, Camara M , Kraus, Molly B. , Harbell, Monica W.

Women's Health Reports | May 10, 2023 | Volume: 4 | Issue: 1 | Pages: No page available

10.1089/whr.2023.0010 | PMID 37096124 Get It

Objective: To evaluate and compare parental leave policies from the top United States (US) hospitals with a focus on inclusivity of all types of parents. Methods: In September and October of 2021, the parental leave policies of the top 20 US hospitals, ranked by the 2021 US News & World report, were evaluated. Parental leave policies were obtained and reviewed through the hospitals' public websites. Hospitals' Human Relations (HR) departments were contacted to confirm the policies. Hospital policies were scored against a rubric created by the authors. Results: Among the top US hospitals (21 total hospitals), 17 (81%) had publicly available policies, and one policy was obtained by contacting HR. Fourteen of the 18 hospitals (77.8%) had a parental leave policy distinctive from short-term disability and offered paid paternity or partner leave. Thirteen hospitals (72.2%) offered parental leave for parents whose children were carried through surrogacy. Fourteen hospitals (77.8%) included adoptive parents; however, only five hospitals (27.8%) specifically included foster parents. The average paid leave for birthing mothers was 7.9 weeks compared to 6.6 weeks for nonbirthing parents. Only three hospitals offered the same leave for birthing and nonbirthing parents. Conclusion: While a few of the top 20 hospitals have paid parental leave policies that are inclusive and equivalent to all parents, many do not and represent an area for improvement. As healthcare industry leaders, these hospitals should strive for inclusive parental leave policies that care for their employees with the same high standards they set for caring for patients.
Daytime Versus Nighttime Ambulatory Blood Pressure Monitoring in Coarctation of Aorta
Egbe, Alexander C. , Miranda, William R. , Connolly, Heidi M. , Kullo, Iftikhar J. , Borlaug, Barry A. , Borlaug, Barry A , Kullo, Iftikhar J

Hypertension | May 10, 2023 | Volume: 80 | Issue: 8 | Pages: No page available

10.1161/hypertensionaha.123.21124 | PMID 37161822 Get It

Subjective Sleep Quality as it Relates to Cognitive and Physical Function in Spinal Muscular Atrophy Patients
Lenzoni, Sabrina , Turcano, Pierpaolo , Casagrande, Elena, Caumo, Luca, Sorarú, Gianni , Pegoraro, Elena , Semenza, Carlo , Wennberg, Alexandra , Casagrande, Elena

Journal of Neuromuscular Diseases | May 10, 2023 | Volume: 10 | Issue: 4 | Pages: 713-717

10.3233/jnd-221627 | PMID 37182894 Get It

Sleep quality and its association with cognition has been widely studied in some neurodegenerative diseases, but less is known about this association in spinal muscular atrophy (SMA). In adult SMA ( n = 21) patients and age-matched controls ( n = 23), we assessed subjectively measured sleep quality and daytime somnolence. Cognition was assessed with a multi-domain neuropsychological battery. Further, we investigated the association between clinical functional scores and sleep questionnaire scores. Among SMA patients, better motor and limb function was associated with better subjective sleep quality ( p’s< 0.05). Clinicians should consider sleep quality in patient care and future studies are needed to better understand these relationships.
A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry
Wu, Jianfeng , Initiative, for the Alzheimer’s Disease Neuroimaging, Chen, Yanxi , Zhu, Wenhui , Reiman, Eric M. , Caselli, Richard J., Thompson, Paul M. , Wang, Junwen , Thompson, Paul M , Wang, Junwen , Initiative, for the Alzheimer’s Disease Neuroimaging, Su, Yi , Caselli, Richard J. , Chen, Kewei , Wang, Yalin

Journal of Alzheimer's Disease | May 10, 2023 | Volume: 93 | Issue: 3 | Pages: 1153-1168

10.3233/jad-230034 | PMID 37182882 Get It

Background: Alzheimer’s disease (AD) is the most common type of age-related dementia, affecting 6.2 million people aged 65 or older according to CDC data. It is commonly agreed that discovering an effective AD diagnosis biomarker could have enormous public health benefits, potentially preventing or delaying up to 40% of dementia cases. Tau neurofibrillary tangles are the primary driver of downstream neurodegeneration and subsequent cognitive impairment in AD, resulting in structural deformations such as hippocampal atrophy that can be observed in magnetic resonance imaging (MRI) scans. Objective: To build a surface-based model to 1) detect differences between APOE subgroups in patterns of tau deposition and hippocampal atrophy, and 2) use the extracted surface-based features to predict cognitive decline. Methods: Using data obtained from different institutions, we develop a surface-based federated Chow test model to study the synergistic effects of APOE, a previously reported significant risk factor of AD, and tau on hippocampal surface morphometry. Results: We illustrate that the APOE-specific morphometry features correlate with AD progression and better predict future AD conversion than other MRI biomarkers. For example, a strong association between atrophy and abnormal tau was identified in hippocampal subregion cornu ammonis 1 (CA1 subfield) and subiculum in e4 homozygote cohort. Conclusion: Our model allows for identifying MRI biomarkers for AD and cognitive decline prediction and may uncover a corner of the neural mechanism of the influence of APOE and tau deposition on hippocampal morphology.
Glycan Node Analysis Detects Varying Glycosaminoglycan Levels in Melanoma-Derived Extracellular Vesicles
Gonçalves, Jenifer Pendiuk , Walker, Sierra A. , león, Jesús S. Aguilar Díaz de , Yang, Yubo, Davidovich, Irina, Busatto, Sara , Talmon, Yeshayahu , Wolfram, Joy , Pendiuk Goncalves, Jenifer , Sarkaria, Jann, Talmon, Yeshayahu , Wolfram, Joy , Sarkaria, Jann N. , Borges, Chad R.

International Journal of Molecular Sciences | May 10, 2023 | Volume: 24 | Issue: 10 | Pages: 8506

10.3390/ijms24108506 | PMID 37239852 Get It

Extracellular vesicles (EVs) play important roles in (patho)physiological processes by mediating cell communication. Although EVs contain glycans and glycosaminoglycans (GAGs), these biomolecules have been overlooked due to technical challenges in comprehensive glycome analysis coupled with EV isolation. Conventional mass spectrometry (MS)-based methods are restricted to the assessment of N-linked glycans. Therefore, methods to comprehensively analyze all glyco-polymer classes on EVs are urgently needed. In this study, tangential flow filtration-based EV isolation was coupled with glycan node analysis (GNA) as an innovative and robust approach to characterize most major glyco-polymer features of EVs. GNA is a molecularly bottom-up gas chromatography-MS technique that provides unique information that is unobtainable with conventional methods. The results indicate that GNA can identify EV-associated glyco-polymers that would remain undetected with conventional MS methods. Specifically, predictions based on GNA identified a GAG (hyaluronan) with varying abundance on EVs from two different melanoma cell lines. Enzyme-linked immunosorbent assays and enzymatic stripping protocols confirmed the differential abundance of EV-associated hyaluronan. These results lay the framework to explore GNA as a tool to assess major glycan classes on EVs, unveiling the EV glycocode and its biological functions.